[2/26/2019]: The ventilator associated pneumonia market, on the basis of end users, is segmented
into hospitals, research centers and clinics. Hospital segment dominates the
global market owing rising incidence of pneumonia and need for immediate medical
assistance. Ventilator-associated pneumonia (VAP) is a type of pneumonia that
happens after endotracheal incubation, featured by the presence of a new or
progressive virus. VAP is predicted to occur in quarter of all mechanically
ventilated patients along with higher risk of being early in course of
hospitalization. Risk for VAP is greatest during the first initial days of
mechanical ventilation between the intubation and development of VAP. In the
recent years, the accumulated risk of death has decreased and is more recently
estimated at a significant percentage.
VAP
is a serious complication of mechanical ventilation which increases the
patient’s stay in ICU and overall length of hospital incurs additional costs
and is a most common of all nosocomial infections contributing to death. The
risk factor is the endotracheal tube as mechanical ventilator support cannot be
performed without the endotracheal tube. The endotracheal tube provides a direct
passageway into the lungs that bypasses natural protection mechanisms. Hence,
the endotracheal tube augments the risk for VAP by; preventing cough,
preventing upper airway filtering, preventing upper airway humidification,
having a cuff that provides a place for secretions to pool in the hypoglottic
area.
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market/request-sample
The
key driving factors responsible for the growth of ventilator associated
pneumonia market includes growth in geriatric population and rising number of
pneumonic patients especially in the cold countries. Additionally, government
funding to eradicate lack of medical infrastructure for sparsely populated
areas is also contributing to the growth of ventilator associated pneumonia
market. On the basis of diagnosis types, the ventilator associated pneumonia
market is segmented into clinical, radiological and microbiological. Clinical
segment dominated the global ventilator associated pneumonia market owing to
growth in number of pneumonic patients.
On
the basis of geographic segmentation, the global associated ventilator
pneumonia market spans North America, Europe, China, Southeast Asia, Japan and
India. North America dominates the global market due to growth in increasing
rates of pneumonias. Europe is the second large market for
ventilator-associated pneumonia (VAP) and is witnessed a higher CAGR during the
assessment period.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market
Market Segment:
This report studies the global
Ventilator Associated Pneumonia (VAP) market, analyzes and researches the
Ventilator Associated Pneumonia (VAP) development status and forecast in United
States, EU, Japan, China, India and Southeast Asia. This report focuses on the
top players in global market, like
•
Philips Respironics
•
Hoffrichter
•
Tyco
•
Teleflex
•
Weinmann
•
ResMed
•
SYSMED
•
Fisher & Paykel
Market segment by Regions/Countries,
this report covers
•
United States
•
EU
•
Japan
•
China
•
India
•
Southeast Asia
Table of Contents
1
Ventilator Associated Pneumonia(VAP) Overview
2
Global Ventilator Associated Pneumonia(VAP) Market Competition by Manufacturers
3
Global Ventilator Associated Pneumonia(VAP) Analysis by Region
4
Global Ventilator Associated Pneumonia(VAP) Analysis by Type
5
Global Ventilator Associated Pneumonia(VAP) Market Analysis by Application
6
Global Ventilator Associated Pneumonia(VAP) Manufacturers Analysis
7
Ventilator Associated Pneumonia(VAP) Technology and Development Trend
8
Research Findings and Conclusion
For More Details Visit @ million insights
No comments:
Post a Comment